Segluromet is a combination medication that contains two active ingredients, empagliflozin and metformin. Empagliflozin belongs to a class of drugs called SGLT2 inhibitors, which work by helping the kidneys remove glucose from the bloodstream through the urine. Metformin is a biguanide medication that helps decrease the amount of glucose produced by the liver and improves the body’s response to insulin.

This combination medication is commonly prescribed to help manage blood sugar levels in adults with type 2 diabetes. By targeting different mechanisms in the body, Segluromet can help improve glycemic control and reduce the risk of complications associated with uncontrolled diabetes.

It is important to follow your healthcare provider’s instructions when taking Segluromet. This medication is typically taken orally with food to help reduce the risk of stomach upset. Your healthcare provider may adjust your dosage based on your individual needs and response to the medication.

As with any medication, Segluromet may cause side effects in some individuals. Common side effects may include urinary tract infections, increased urination, and gastrointestinal issues. It is important to report any unusual or severe side effects to your healthcare provider.

Before starting Segluromet, inform your healthcare provider about any medical conditions you have, especially kidney or liver problems. It is also important to disclose any other medications or supplements you are taking to avoid potential drug interactions.

Overall, Segluromet can be a valuable tool in managing type 2 diabetes when used as part of a comprehensive treatment plan that includes a healthy diet, regular exercise, and monitoring blood sugar levels. If you have any questions or concerns about Segluromet, don’t hesitate to discuss them with your healthcare provider.